HLA class I expression, a predictor of breast cancer prognosis

HLA class I expression, a predictor of breast cancer prognosis - HLA class I expression, a predictor of breast cancer prognosis

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000054872

Enrollment

150

Registered

2024-07-04

Start date

2024-06-06

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

operable breast cancer patients

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with pathologically confirmed breast cancer Patients who have undergone breast cancer surgery Patients for whom information on medical treatment and prognosis can be obtained from the medical record.

Exclusion criteria

Exclusion criteria: Patients with active other cancers Patients who have requested not to participate in this study by submitting a publicly available opt-out document.

Design outcomes

Primary

Measure	Time frame
disease free survival	—

Secondary

Measure	Time frame
overall survival	—

Countries

Japan

Contacts

Public ContactHiroaki Shima

Sapporo Medical University Departure of Surgery, Surgical Oncology and Science

simahiro@sapmed.ac.jp+81-11-611-2111

Outcome results